Lung Adverse Effects in Patients Taking Trastuzumab Deruxtecan
Cancer patients treated with the targeted agent need to be closely monitored for interstitial lung disease/pneumonitis as an adverse event, say researchers reporting a new analysis.
Medscape Medical News
source https://www.medscape.com/viewarticle/979376?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/979376?src=rss
Comments
Post a Comment